C. Grafton

711 total citations
18 papers, 531 citations indexed

About

C. Grafton is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, C. Grafton has authored 18 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in C. Grafton's work include Lung Cancer Diagnosis and Treatment (7 papers), Lung Cancer Research Studies (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). C. Grafton is often cited by papers focused on Lung Cancer Diagnosis and Treatment (7 papers), Lung Cancer Research Studies (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). C. Grafton collaborates with scholars based in Canada and United Kingdom. C. Grafton's co-authors include David E. Woolley, Nevin Murray, Anand P. Shah, David Osoba, R.N. Fairey, Karen Goddard, Andrea Bezjak, Michael Palmer, C. Lochrin and Joseph L. Pater and has published in prestigious journals such as Journal of Clinical Oncology, Cochrane Database of Systematic Reviews and British Journal of Cancer.

In The Last Decade

C. Grafton

17 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Grafton Canada 9 349 242 217 141 50 18 531
Timothy F. Kozelsky United States 11 352 1.0× 388 1.6× 178 0.8× 87 0.6× 69 1.4× 17 718
A. Badzio Poland 15 323 0.9× 169 0.7× 169 0.8× 132 0.9× 125 2.5× 47 620
B. Pellae-Cosset France 10 244 0.7× 234 1.0× 74 0.3× 40 0.3× 109 2.2× 21 488
Haruhito Kamei Japan 9 389 1.1× 465 1.9× 53 0.2× 53 0.4× 66 1.3× 37 573
Peter Farha United States 9 340 1.0× 272 1.1× 115 0.5× 81 0.6× 43 0.9× 15 442
Natalyn Hawk United States 9 432 1.2× 175 0.7× 164 0.8× 126 0.9× 91 1.8× 25 573
Sehhoon Park South Korea 14 291 0.8× 124 0.5× 157 0.7× 96 0.7× 69 1.4× 53 499
I. Garassino Italy 13 271 0.8× 342 1.4× 51 0.2× 92 0.7× 106 2.1× 28 547
Virag Dandekar United States 4 234 0.7× 151 0.6× 48 0.2× 109 0.8× 168 3.4× 6 527
G. Haensgen Germany 10 130 0.4× 74 0.3× 73 0.3× 100 0.7× 110 2.2× 15 502

Countries citing papers authored by C. Grafton

Since Specialization
Citations

This map shows the geographic impact of C. Grafton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Grafton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Grafton more than expected).

Fields of papers citing papers by C. Grafton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Grafton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Grafton. The network helps show where C. Grafton may publish in the future.

Co-authorship network of co-authors of C. Grafton

This figure shows the co-authorship network connecting the top 25 collaborators of C. Grafton. A scholar is included among the top collaborators of C. Grafton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Grafton. C. Grafton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Williams, Chris, Iveta Simera, & C. Grafton. (2002). Short versus long duration infusions of paclitaxel for any advanced adenocarcinoma. Cochrane Database of Systematic Reviews. CD003911–CD003911. 9 indexed citations
3.
Bezjak, Andrea, Peter Dixon, Michael Brundage, et al.. (2002). Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15). International Journal of Radiation Oncology*Biology*Physics. 54(3). 719–728. 117 indexed citations
4.
Bezjak, Andrea, Peter Dixon, Michael Brundage, et al.. (2001). Randomized study of single versus fractionated radiotherapy (RT) in the palliation of non-small cell lung cancer; NCIC CTG SC.15. International Journal of Radiation Oncology*Biology*Physics. 51(3). 20–20. 8 indexed citations
5.
Weir, Lorna, Bassam A. Masri, C. Grafton, et al.. (2000). Local Excision Without Radiation for High‐Grade Soft‐Tissue Sarcoma ofthe Extremity and Superficial Trunk. Sarcoma. 4(3). 113–117. 2 indexed citations
6.
Dixon, Peter, Michael Brundage, Michael Palmer, et al.. (2000). Characteristics of lung cancer patients entered on a Canadian palliative radiotherapy study (National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC.15 study). Lung Cancer. 29(1). 171–171. 8 indexed citations
7.
Murray, Nevin, Robert B. Livingston, Frances A. Shepherd, et al.. (1999). Randomized Study of CODE Versus Alternating CAV/EP for Extensive-Stage Small-Cell Lung Cancer: An Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group. Journal of Clinical Oncology. 17(8). 2300–2300. 87 indexed citations
8.
Westeel, V., Nevin Murray, Karen A. Gelmon, et al.. (1998). New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimen.. Journal of Clinical Oncology. 16(5). 1940–1947. 42 indexed citations
9.
Murray, Nevin, C. Grafton, Anand P. Shah, et al.. (1998). Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancer.. Journal of Clinical Oncology. 16(10). 3323–3328. 65 indexed citations
11.
Wong, Eric, Stephen Lam, C. Grafton, et al.. (1994). High-Dose Rate Brachytherapy for Obstructive Bronchial Tumors. Journal of Bronchology. 1(2). 99–104.
12.
Lam, Stephen, C. Grafton, P. Coy, Nicholas Voss, & R.N. Fairey. (1993). Combined photodynamic therapy using Photofrin and radiotherapy versus radiotherapy alone in patients with inoperable obstructive nonsmall-cell bronchogenic carcinoma. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 1616. 20–20. 6 indexed citations
13.
Murray, Nevin, Anand P. Shah, David Osoba, et al.. (1991). Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer.. Journal of Clinical Oncology. 9(9). 1632–1638. 91 indexed citations
14.
Grafton, C., Stephen Lam, Nicholas Voss, et al.. (1991). High dose rate endobronchial brachytherapy using the microselectron. Lung Cancer. 7. 97–97. 2 indexed citations
15.
Quirt, Ian, et al.. (1987). Phase II study of mitoxantrone in untreated and previously minimally treated patients with metastatic soft tissue sarcomas.. PubMed. 71(11). 1109–10. 7 indexed citations
16.
Grafton, C., et al.. (1985). Review of conservative surgery in early breast cancer. The American Journal of Surgery. 149(5). 599–601. 6 indexed citations
17.
Woolley, David E. & C. Grafton. (1980). Collagenase immunolocalization studies of cutaneous secondary melanomas. British Journal of Cancer. 42(2). 260–265. 51 indexed citations
18.
Pettit, John E., et al.. (1976). Quantitative Studies of Splenic Erythropoiesis in Polycythaemia Vera and Myelofibrosis. British Journal of Haematology. 34(3). 465–475. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026